NeuPath Health Announces Voting Results from the Annual General and Special Meeting of Shareholders

NeuPathNews

TORONTO, ONTARIO, June 28, 2021 – NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 25, 2021.

The results of the director elections were as follows:

Name Votes in
Favour
% Votes in
Favour
Votes
Withheld
% Votes
Withheld

Dianne Carmichael

22,614,341 98.97% 235,250 1.03%
Jolyon Burton

22,812,591

99.84% 37,000

0.16%

Daniel Chicoine

22,431,591

98.17% 418,000

1.83%

Sasha Cucuz

22,427,591

98.15% 422,000

1.85%

Dan Legault

22,438,591

98.20% 411,000

1.80%

Grishanth Ram

22,532,791

98.61% 316,800

1.39%

Joseph Walewicz

22,433,591 98.18% 416,000

1.82%

The shareholders of the Company also voted: (i) to set the number of directors of the Company at seven directors for the ensuing year; (ii) to reappoint Ernst & Young LLP, Chartered Professional Accounts, Licensed Public Accountants, as auditors of the Company for the ensuing year; and (iii) to approve, ratify and confirm the Company’s amended stock option plan in the form attached as Schedule “A” to the management information circular dated May 14, 2021 prepared in connection with the Meeting.

 About NeuPath

NeuPath is a vertically integrated health care provider utilizing research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by chronic pain, spinal injuries, sport-related injuries, and concussions. With equity ownership in fifteen clinics in Ontario and Alberta, NeuPath is building out a large-scale network to better serve patients across Canada and the United States. NeuPath is focused on transforming the hope of a better life into the reality of a life more fully lived.

 

For more information, please contact:

Johanna Gonzalez
johanna@bristolir.com
905 326 1888 ext 9

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS THE RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.